Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400499 · ClinicalTrials.gov registry record

Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by VA Office of Research and Development.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT05400499 is a study of Parkinson's Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400499, a study of Parkinson's Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment, frequently affects the quality of life in patients with Parkinson's disease. Our study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence by integrating the patient-specific deep brain stimulation models and high-resolution eye-tracking measures. The knowledge gained will allow us to find the most beneficial stimulation location and parameters for improving binocular coordination and vergence while preserving the ability to treat motor symptoms in Parkinson's disease.

Conditions Studied

Study Locations (1)

Ohio

  • Louis Stokes VA Medical Center, Cleveland, OH - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-10-04
Est. Completion 2026-07-01

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05400499

The ClinicalTrials.gov registry entry for NCT05400499 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (94% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT05400499 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05400499 about?

NCT05400499 is a clinical study titled "Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease". Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment, frequently affects the quality of life in patients with Parkinson's disease. Our study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence by i...

What is the current status of trial NCT05400499?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2022-10-04. Estimated completion is 2026-07-01.

What conditions does trial NCT05400499 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT05400499?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400499 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.